0
     

Report Added
Report already added
Dementia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Dementia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dementia - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Dementia (Central Nervous System) pipeline landscape.

Dementia is the loss of mental functions such as thinking, memory, and reasoning that is severe enough to interfere with a person's daily functioning. Symptoms include memory loss, hallucinations, agitation, personality changes and difficulty with coordination and motor functions. Risk factors include age, smoking, obesity, high blood pressure, inflammation and cardiovascular diseases.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Dementia - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on the therapeutics under development for Dementia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Dementia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dementia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 14, 43, 31, 2, 89, 58 and 3 respectively. Similarly, the Universities portfolio in Preclinical, Discovery and Unknown stages comprises 14, 5 and 1 molecules, respectively.

Dementia (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Dementia (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Dementia (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Dementia (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Dementia (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Dementia (Central Nervous System)

Reasons to Buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Dementia (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Dementia (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Dementia - Overview
Dementia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Dementia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Dementia - Companies Involved in Therapeutics Development
Dementia - Drug Profiles
Dementia - Dormant Projects
Dementia - Discontinued Products
Dementia - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Dementia, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Target, 2022 (Contd..1)
Number of Products by Stage and Target, 2022 (Contd..2)
Number of Products by Stage and Target, 2022 (Contd..3)
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Mechanism of Action, 2022 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2022 (Contd..2)
Number of Products by Stage and Mechanism of Action, 2022 (Contd..3)
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Dementia - Pipeline by 2N Pharma ApS, 2022
Dementia - Pipeline by AbbVie Inc, 2022
Dementia - Pipeline by Acadia Pharmaceuticals Inc, 2022
Dementia - Pipeline by Actinogen Medical Ltd, 2022
Dementia - Pipeline by AcuraStem Inc, 2022
Dementia - Pipeline by Adamed Pharma SA, 2022
Dementia - Pipeline by ADEL Inc, 2022
Dementia - Pipeline by AFFiRiS AG, 2022
Dementia - Pipeline by AgeneBio Inc, 2022
Dementia - Pipeline by AIBIOS Co Ltd, 2022
Dementia - Pipeline by Alector Inc, 2022
Dementia - Pipeline by Alkermes Plc, 2022
Dementia - Pipeline by AlphaCognition Inc, 2022
Dementia - Pipeline by Alterity Therapeutics Ltd, 2022
Dementia - Pipeline by Alzamend Neuro Inc, 2022
Dementia - Pipeline by Amarantus Bioscience Holdings Inc, 2022
Dementia - Pipeline by Anavex Life Sciences Corp, 2022
Dementia - Pipeline by Anhorn Medicines Co Ltd, 2022
Dementia - Pipeline by Annovis Bio Inc, 2022
Dementia - Pipeline by Aphios Corp, 2022
Dementia - Pipeline by Applied Genetic Technologies Corp, 2022
Dementia - Pipeline by Aprinoia Therapeutics Inc, 2022
Dementia - Pipeline by Aptinyx Inc, 2022
Dementia - Pipeline by AriBio, 2022
Dementia - Pipeline by Arkuda Therapeutics Inc, 2022
Dementia - Pipeline by Arvinas Inc, 2022
Dementia - Pipeline by Asahi Kasei Pharma Corp, 2022
Dementia - Pipeline by Asceneuron SA, 2022
Dementia - Pipeline by AskAt Inc, 2022
Dementia - Pipeline by Astrogen Ltd, 2022
Dementia - Pipeline by Athira Pharma Inc, 2022
Dementia - Pipeline by AULBIO Co Ltd, 2022
Dementia - Pipeline by Aurum Biosciences Ltd, 2022
Dementia - Pipeline by Autifony Therapeutics Ltd, 2022
Dementia - Pipeline by Avanir Pharmaceuticals Inc, 2022
Dementia - Pipeline by AviadoBio Ltd, 2022
Dementia - Pipeline by Avineuro Pharmaceuticals Inc, 2022
Dementia - Pipeline by Avrion Therapeutics AG, 2022
Dementia - Pipeline by Axon Neuroscience SE, 2022
Dementia - Pipeline by Axsome Therapeutics Inc, 2022
Dementia - Pipeline by Bioasis Technologies Inc, 2022
Dementia - Pipeline by Biogen Inc, 2022
Dementia - Pipeline by Biom Therapeutics LLC, 2022
Dementia - Pipeline by Biorchestra Co Ltd, 2022
Dementia - Pipeline by BioXcel Therapeutics Inc, 2022
Dementia - Pipeline by CAMP4 Therapeutics Corp, 2022
Dementia - Pipeline by Cellivery Therapeutics Inc, 2022
Dementia - Pipeline by Cellular Biomedicine Group Ltd, 2022
Dementia - Pipeline by Cennerv Pharma (S) Pte Ltd, 2022
Dementia - Pipeline by Cerevel Therapeutics Holdings Inc, 2022
Dementia - Pipeline by ChunLab Inc, 2022
Dementia - Pipeline by Cogentis Therapeutics Inc, 2022
Dementia - Pipeline by Cognition Therapeutics Inc, 2022
Dementia - Pipeline by Cortice Biosciences Inc, 2022
Dementia - Pipeline by Coya Therapeutics Inc, 2022
Dementia - Pipeline by CSPC NBP Pharmaceutical Co Ltd, 2022
Dementia - Pipeline by CuraSen Therapeutics Inc, 2022
Dementia - Pipeline by Cyclerion Therapeutics Inc, 2022
Dementia - Pipeline by Dadang & BIO Co Ltd, 2022
Dementia - Pipeline by Daewoong Pharmaceutical Co Ltd, 2022
Dementia - Pipeline by Denali Therapeutics Inc, 2022
Dementia - Pipeline by DiaMedica Therapeutics Inc, 2022
Dementia - Pipeline by Dongkook Pharmaceutical Co Ltd, 2022
Dementia - Pipeline by Dr. August Wolff GmbH & Co KG Arzneimittel, 2022
Dementia - Pipeline by Echo Pharmaceuticals BV, 2022
Dementia - Pipeline by EIP Pharma LLC, 2022
Dementia - Pipeline by Eisai Co Ltd, 2022
Dementia - Pipeline by Eli Lilly and Co, 2022
Dementia - Pipeline by ENCEFA, 2022
Dementia - Pipeline by Ensol Biosciences Inc, 2022
Dementia - Pipeline by Enterin Inc, 2022
Dementia - Pipeline by EVER Neuro Pharma GmbH, 2022
Dementia - Pipeline by Expansion Therapeutics Inc, 2022
Dementia - Pipeline by Galimedix Therapeutics Ltd, 2022
Dementia - Pipeline by Generian Pharmaceuticals Inc, 2022
Dementia - Pipeline by Gismo Therapeutics Inc, 2022
Dementia - Pipeline by GraySpace Therapeutics Inc, 2022
Dementia - Pipeline by Guangzhou Magpie Pharmaceutical Co Ltd, 2022
Dementia - Pipeline by HanAll Biopharma Co Ltd, 2022
Dementia - Pipeline by Hemostemix Inc, 2022
Dementia - Pipeline by Herophilus, 2022
Dementia - Pipeline by HLB Pharmaceutical Co Ltd, 2022
Dementia - Pipeline by Hyundai Pharma Co Ltd, 2022
Dementia - Pipeline by IGC Pharma LLC, 2022
Dementia - Pipeline by Immungenetics AG, 2022
Dementia - Pipeline by ImStar Therapeutics Inc, 2022
Dementia - Pipeline by Inhibikase Therapeutics Inc, 2022
Dementia - Pipeline by Intra-Cellular Therapies Inc, 2022
Dementia - Pipeline by IntraBio Ltd, 2022
Dementia - Pipeline by Inventage Lab Inc, 2022
Dementia - Pipeline by Ionis Pharmaceuticals Inc, 2022
Dementia - Pipeline by IRLAB Therapeutics AB, 2022
Dementia - Pipeline by Jazz Pharmaceuticals Plc, 2022
Dementia - Pipeline by Johnson & Johnson, 2022
Dementia - Pipeline by KeifeRx LLC, 2022
Dementia - Pipeline by Kogenix Therapeutics Inc, 2022
Dementia - Pipeline by Korea Pharma Co Ltd, 2022
Dementia - Pipeline by Kuano Ltd, 2022
Dementia - Pipeline by Kwang Dong Pharmaceutical Co Ltd, 2022
Dementia - Pipeline by Lachesis Biosciences Ltd, 2022
Dementia - Pipeline by Locanabio Inc, 2022
Dementia - Pipeline by Luye Pharma Group Ltd, 2022
Dementia - Pipeline by MediPost Co Ltd, 2022
Dementia - Pipeline by Merck & Co Inc, 2022
Dementia - Pipeline by Merz Pharma GmbH & Co KgaA, 2022
Dementia - Pipeline by Metro International Biotech LLC, 2022
Dementia - Pipeline by MGC Pharmaceuticals Ltd, 2022
Dementia - Pipeline by MThera Pharma Co Ltd, 2022
Dementia - Pipeline by MYND Life Sciences Inc, 2022
Dementia - Pipeline by Neuramedy Co Ltd, 2022
Dementia - Pipeline by Neurimmune Holding AG, 2022
Dementia - Pipeline by Neurokine Therapeutics, 2022
Dementia - Pipeline by NeuroScientific Biopharmaceuticals Ltd, 2022
Dementia - Pipeline by NeuroTau Inc, 2022
Dementia - Pipeline by Neuvivo Inc, 2022
Dementia - Pipeline by NLS Pharmaceutics AG, 2022
Dementia - Pipeline by Novartis AG, 2022
Dementia - Pipeline by Novo Nordisk AS, 2022
Dementia - Pipeline by Oligomerix inc, 2022
Dementia - Pipeline by Orchard Therapeutics Plc, 2022
Dementia - Pipeline by Oryzon Genomics SA, 2022
Dementia - Pipeline by Otsuka Pharmaceutical Co Ltd, 2022
Dementia - Pipeline by P2D Inc, 2022
Dementia - Pipeline by Pacific Northwest Biotechnology LLC, 2022
Dementia - Pipeline by Palisades Therapeutics, 2022
Dementia - Pipeline by Park of Active Molecules, 2022
Dementia - Pipeline by Passage Bio Inc, 2022
Dementia - Pipeline by Plico Biotech Inc, 2022
Dementia - Pipeline by Prediction BioSciences SAS, 2022
Dementia - Pipeline by ProMIS Neurosciences Inc, 2022
Dementia - Pipeline by Prothena Corp Plc, 2022
Dementia - Pipeline by Psy Therapeutics Inc, 2022
Dementia - Pipeline by PurMinds NeuroPharma Inc, 2022
Dementia - Pipeline by QurAlis Corporation, 2022
Dementia - Pipeline by Reata Pharmaceuticals Inc, 2022
Dementia - Pipeline by Reborna Biosciences Inc, 2022
Dementia - Pipeline by Resverlogix Corp, 2022
Dementia - Pipeline by Reven Holdings Inc, 2022
Dementia - Pipeline by Rubedo Life Sciences Inc, 2022
Dementia - Pipeline by Sage Therapeutics Inc, 2022
Dementia - Pipeline by Samus Therapeutics Inc, 2022
Dementia - Pipeline by Shaperon Inc, 2022
Dementia - Pipeline by Sinfonia Biotherapeutics Inc, 2022
Dementia - Pipeline by Sio Gene Therapies Inc, 2022
Dementia - Pipeline by SK Chemicals Co Ltd, 2022
Dementia - Pipeline by SOLA Biosciences LLC, 2022
Dementia - Pipeline by Stealth BioTherapeutics Corp, 2022
Dementia - Pipeline by Stemedica Cell Technologies Inc, 2022
Dementia - Pipeline by Sun Pharma Advanced Research Company Ltd, 2022
Dementia - Pipeline by Suven Life Sciences Ltd, 2022
Dementia - Pipeline by SyneuRx International Corp, 2022
Dementia - Pipeline by T3D Therapeutics Inc, 2022
Dementia - Pipeline by Targeted Pharmaceuticals LLC, 2022
Dementia - Pipeline by TauRx Therapeutics Ltd, 2022
Dementia - Pipeline by Teitur Trophics ApS, 2022
Dementia - Pipeline by Theranexus SAS, 2022
Dementia - Pipeline by Time Therapeutics Inc, 2022
Dementia - Pipeline by Towa Pharmaceutical Co Ltd, 2022
Dementia - Pipeline by Tranquis Therapeutics Inc, 2022
Dementia - Pipeline by Transposon Therapeutics Inc, 2022
Dementia - Pipeline by UCB SA, 2022
Dementia - Pipeline by UniQure NV, 2022
Dementia - Pipeline by Unity Biotechnology Inc, 2022
Dementia - Pipeline by Vanqua Bio Inc, 2022
Dementia - Pipeline by Vaxxinity Inc, 2022
Dementia - Pipeline by Verge Genomics Inc, 2022
Dementia - Pipeline by Voyager Therapeutics Inc, 2022
Dementia - Pipeline by Wave Life Sciences Ltd, 2022
Dementia - Pipeline by Whan In Pharm Co Ltd, 2022
Dementia - Pipeline by Yumanity Therapeutics Inc, 2022
Dementia - Dormant Projects, 2022
Dementia - Discontinued Products, 2022

List of Figures
Number of Products under Development for Dementia, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

Report Title: Dementia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Dental Imaging Systems: Global Markets

Dental Imaging Systems: Global Markets

Telecom operators’ strategies in the health market

Telecom operators’ strategies in the health market

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline